Genomic Biomarkers Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Genomic Biomarkers Market - By Type (Oncology, Cardiovascular diseases, Neurological diseases and Others) By Application (Diagnostics, Research laboratories, Hospital, Other) By Region (North America, Europe, Asia Pacific, Middle East & Africa, RoW) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 189

Status: Published

Report Code: EMR100736

The global genomic biomarkers market valued USD 4.46 billion in 2020 and is expected to reach a valuation at USD 11.2 billion by 2027 and is expected to grow with a CAGR of 14% over the forecast period. The driving factors influencing the global genomic biomarkers market include the growing prevalence for colorectal cancers, ovarian, gastric, increasing demand for minimally invasive procedures, rising developments in infrastructure for data sharing and analysis such as bioinformatics, introducing advancements in technologies, and rising concerns about genomics biomarkers.

As genomics biomarkers have complex processes and stringent government regulations the demand for the global genomic biomarker market is expected to hamper the growth. With the increasing awareness of biomarkers to diagnose fatal disease such as reimbursement issues and cardiovascular diseases are being solved with the intervention of regulatory authorities is expected to propel the growth of the global genomic biomarkers in the coming years.

Biomarkers are non-invasive tools used in imaging technology to provide clear imaging of oncology tumors and other problems. Moreover, it eliminates the opportunity of radiation exposure during performing imaging through CT scans and MRI scans. It is reflected as the expression of a gene, function of a gene in normal biologic to test hyperkalemia, test high blood pressure.

In terms of market players, the global genomic biomarkers market is competitive and fragmented with the presence of various kind of different vendors including Thermo Fisher Scientific Inc., Aepodia SA, QIAGEN, Inc., Eurofins Scientific, Liquid Genomics, Bio-Rad Laboratories, Inc., Genomic Health, F. Hoffmann-La Roche AG, Myriad Genetics, Epigenomics AG, and AROS Applied Biotechnology A/S among others.

Analyst Commentary:

With the increasing popularity of limitations of diagnosis and treatment and personalized medicines, the genomic biomarkers are generating a huge scope of opportunities across the globe. With a variety of fields of medicines, from cancer to psychiatry patients are moving towards tailored treatments on the basis of clinical or biological characteristics. The biomarkers play a major role in personalized medicines. Moreover, rise in the field of personalized medicines along with applications in selection of targeted therapies, diagnosis, and prognosis the demand for genomic biomarkers is expected to project maximum popularity over the forecast period.

With the growing risk of disease and response to therapy, the ongoing development and identification of biomarkers specific to a disease and individual patients is believed to be one of the major for personalized medicine. The field of personalized medicine is expected to project a wide range of opportunities in the coming years.

Due to the steady growth, the industry is planning for the expansion of services programs for research and development of colorectal cancer diagnostics solutions to be prepared for the battle-ground communication systems. This boosts the growth of the global genomic biomarkers market in the coming years. The leading companies in the global genomic biomarkers market are planning strategies such as joint ventures to generate long-term profits, acquisitions, and strengthen the product assortment.

Segmentation:

The global genomic biomarkers market is categorized into several segmentations including type overview, cancer type overview, profiling technology overview, application, and regions. Based on the type overview, the global genomic biomarkers market is fragmented into Protein Biomarker, Genetic Biomarker, cell, viral, carbohydrate biomarkers, and Other Cancer Biomarkers. Based on the cancer type overview, the global genomic biomarkers market is segregated into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Non-hodgkin’s lymphoma, Melanoma, Leukemia, Thyroid Cancer, Bladder Cancer, Kidney Cancer, multiple myeloma, cervical, central nervous system cancer, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancer. The cancer type segment is about to project faster growth along with tremendous popularity in the market owing to the increasing popularity of limitations of diagnosis and treatment and personalized medicines, the genomic biomarkers are generating a huge scope of opportunities across the globe. This boosts the demand for the global genomic biomarkers market with a tremendous growth over the forecast period.

Based on the profiling technology overview, the global genomic biomarkers market is classified into Omics Technologies, Genomics, Proteomics, Imaging Technologies, Ultrasound, CT, MRI, PET, Mammography, Immunoassays , Cytogenetics, In Situ Hybridization, Bioinformatics, and Other Cytogenetics. Based on the application overview, the global genomic biomarkers market is classified into Diagnostics, Research, Prognostics, Risk Assessment, personalized medicine, surrogate endpoints, therapeutics, and Other Applications.

Regional Analysis:

Based on region, the global genomic biomarkers market is widespread to the Middle East and Africa, Egypt, Saudi Arabia, Canada, South Africa, Asia Pacific, Argentina, Mexico, Korea, India, France, Turkey, Nigeria, UAE, Europe, Japan, China, UK, Russia, South America, Brazil, Italy, North America, Southeast Asia, Germany, USA, and Columbia.

North America is anticipated to hold the largest market size in the genomic biomarkers market, followed by Europe. This is due to the increasing presence of key vendors in the region. Furthermore, Europe is expected to hold the highest market size in the market resulting in GDPR compliance. Due to the increasing technological advancement in Asia Pacific region, the factors influencing the genomic biomarkers market include growing prevalence for colorectal cancers, ovarian, gastric, increasing demand for minimally invasive procedures, rising developments in infrastructure for data sharing and analysis such as bioinformatics, introducing advancements in technologies, and rising concerns about genomics biomarkers.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Genomic Biomarkers Market
Chapter 5. Global Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Genomic Biomarkers Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Oncology
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Cardiovascular diseases
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Neurological diseases
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Others
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Genomic Biomarkers Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Diagnostics
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Research laboratories
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Hospital
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Others
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Genomic Biomarkers Market Overview, By Geography, 2015 - 2027(USD Million)
7.1. Global Genomic Biomarkers Market Share, By Geography, 2015 - 2027(USD Million)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 8. North America Genomic Biomarkers Market Overview, By Countries, 2015 - 2027(USD Million)
8.1. North America Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.3. North America Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4. North America Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4.2. Canada Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 9. Europe Genomic Biomarkers Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. Europe Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. Europe Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.1.3. Germany Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.2. France
9.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.2.3. France Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.3. UK
9.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.3.3. UK Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.4.3. Italy Genomic Biomarkers Market Overview, By Application 2015 - 2027(USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.5.3. Spain Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Size and projections, 2015 – 2027
9.1.4.6.2. Rest of Europe Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.6.3. Rest of Europe Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
Chapter 10. Asia Pacific Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.1.3. India Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.4.2.2. China Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.2.3. China Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.3.3. Japan Genomic Biomarkers Market Overview, By Application, 2015 - 2027(USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.4.4.2. South Korea Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.4.3. South Korea Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Genomic Biomarkers Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.5.3. Rest of Asia Pacific Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 12. South America Genomic Biomarkers Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Genomic Biomarkers Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. South America Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. South America Genomic Biomarkers Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.5. Brazil
12.1.5.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.5.2. Brazil Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3. Brazil Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.6. Argentina
12.1.6.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.6.2. Argentina Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.3. Argentina Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.7. Rest of South America
12.1.7.1. Market Size and projections, 2015 – 2027
12.1.7.2. Rest of South America Genomic Biomarkers Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.7.3. Rest of South America Genomic Biomarkers Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Size development
Chapter 14. Key Vendor Analysis
14.1. Thermo Fisher Scientific Inc.
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. F. Hoffmann-La Roche Ltd
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Myriad Genetics
14.3.1. Company overview
14.3.2. Financial performance
14.3.3. Product Benchmarking
14.3.4. Recent initiatives
14.4. Eurofins Scientific
14.5. QIAGEN
14.6. Others
Chapter 15. Genomic Biomarkers Market Cost Analysis
15.1. Genomic Biomarkers Market Key Raw Material Analysis
15.1.1. Key Size
15.1.2. Price Trend of Key Size
15.1.3. Key Suppliers of Size
15.1.4. Market Concentration Rate of Size
15.1.5. Labor Cost
Chapter 16. Sourcing Strategy and Downstream Buyers
16.1. Genomic Biomarkers Market Chain Analysis
16.2. Upstream Size Sourcing
16.3. Genomic Biomarkers Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Size
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Genomic Biomarkers Market share, By Type, 2020 & 2027 (%)
10. Global Genomic Biomarkers Market share, by Oncology, By Type, 2015 - 2027 (USD Million)
11. Global Genomic Biomarkers Market share, by Cardiovascular diseases, By Type, 2015 - 2027 (USD Million)
12. Global Genomic Biomarkers Market share, by Neurological diseases, By Type, 2015 - 2027 (USD Million)
13. Global Genomic Biomarkers Market share, by Others, By Type, 2015 - 2027 (USD Million)
14. Global Genomic Biomarkers Market share, By Application, 2020 & 2027 (%)
15. Global Genomic Biomarkers Market share, by Diagnostics, By Application, 2015 - 2027 (USD Million)
16. Global Genomic Biomarkers Market share, by Research laboratories, By Application 2015 - 2027 (USD Million)
17. Global Genomic Biomarkers Market share, by Hospital, By Application 2015 - 2027 (USD Million)
18. Global Genomic Biomarkers Market share, by Others, By Application 2015 - 2027 (USD Million)
19. Global Genomic Biomarkers Market share, by region, 2020 & 2027 (%)
20. Global Genomic Biomarkers Market share, by region, 2015 - 2027(USD Million)
21. North America Genomic Biomarkers Market, 2015 - 2027(USD Million)
22. North America Genomic Biomarkers Market share, by Countries, 2020 & 2027 (%)
23. U.S. Genomic Biomarkers Market, 2015 - 2027(USD Million)
24. Canada Genomic Biomarkers Market, 2015 - 2027(USD Million)
25. Mexico Genomic Biomarkers Market, 2015 - 2027(USD Million)
26. Europe Genomic Biomarkers Market, 2015 - 2027(USD Million)
27. Europe Genomic Biomarkers Market share, by Countries, 2020 & 2027 (%)
28. Spain Genomic Biomarkers Market, 2015 - 2027(USD Million)
29. UK Genomic Biomarkers Market, 2015 - 2027(USD Million)
30. Italy Genomic Biomarkers Market, 2015 - 2027(USD Million)
31. Germany Genomic Biomarkers Market, 2015 - 2027(USD Million)
32. France Genomic Biomarkers Market, 2015 - 2027(USD Million)
33. Rest of Europe Genomic Biomarkers Market, 2015 - 2027(USD Million)
34. Asia-Pacific Genomic Biomarkers Market, 2015 - 2027(USD Million)
35. Asia-Pacific Genomic Biomarkers Market share, by Countries, 2020 & 2027 (%)
36. China Genomic Biomarkers Market, 2015 - 2027(USD Million)
37. India Genomic Biomarkers Market, 2015 - 2027(USD Million)
38. Australia Genomic Biomarkers Market, 2015 - 2027(USD Million)
39. Japan Genomic Biomarkers Market, 2015 - 2027(USD Million)
40. Rest of Asia-Pacific Genomic Biomarkers Market, 2015 - 2027(USD Million)
41. Middle East & Africa Genomic Biomarkers Market, 2015 - 2027(USD Million)
42. Middle East & Africa Genomic Biomarkers Market share, by Countries, 2020 & 2027 (%)
43. GCC Genomic Biomarkers Market, 2015 - 2027(USD Million)
44. South Africa Genomic Biomarkers Market, 2015 - 2027(USD Million)
45. Rest Of Middle East & Africa Genomic Biomarkers Market, 2015 - 2027(USD Million)
46. South America Genomic Biomarkers Market, 2015 - 2027(USD Million)
47. Brazil Genomic Biomarkers Market, 2015 - 2027(USD Million)
48. Mexico Genomic Biomarkers Market, 2015 - 2027(USD Million)
49. Argentina Genomic Biomarkers Market, 2015 - 2027(USD Million)
50. Rest Of South America Genomic Biomarkers Market, 2015 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Genomic Biomarkers Market, 2015-2027 (USD Million)
4. Genomic Biomarkers requirement, by country, 2015-2027, (USD Million)
5. North America Genomic Biomarkers Market, By Type, 2015-2027 (USD Million)
6. North America Genomic Biomarkers Market, By Application, 2015-2027 (USD Million)
7. Europe Genomic Biomarkers Market, By Type, 2015-2027 (USD Million)
8. Europe Genomic Biomarkers Market, By Application, 2015-2027 (USD Million)
9. Asia Pacific Genomic Biomarkers Market, By Type, 2015-2027 (USD Million)
10. Asia Pacific Genomic Biomarkers Market, By Application, 2015-2027 (USD Million)
11. Middle East & Africa Genomic Biomarkers Market, By Type, 2015-2027 (USD Million)
12. Middle East & Africa Genomic Biomarkers Market, By Application, 2015-2027 (USD Million)
13. South America Genomic Biomarkers Market, By Type, 2015-2027 (USD Million)
14. South America Genomic Biomarkers Market, By Application, 2015-2027 (USD Million)
15. Global Genomic Biomarkers Market, Company Market Share, 2020 - 2027 (%)
16. Thermo Fisher Scientific Inc.: Product Benchmarking
17. Thermo Fisher Scientific Inc.: Financial Performance
18. F. Hoffmann-La Roche Ltd: Product Benchmarking
19. F. Hoffmann-La Roche Ltd: Financial Performance
20. Myriad Genetics.: Product Benchmarking
21. Myriad Genetics.: Financial Performance
22. Eurofins Scientific: Product Benchmarking
23. Eurofins Scientific: Financial Performance
24. QIAGEN: Product Benchmarking
25. QIAGEN: Financial Performance

The Leading Key Players in Genomic Biomarkers Market

Thermo Fisher Scientific Inc.
Aepodia SA
QIAGEN Inc.
Eurofins Scientific
Liquid Genomics
Bio-Rad Laboratories Inc.
Genomic Health
F. Hoffmann-La Roche AG
Myriad Genetics
Epigenomics AG
AROS Applied Biotechnology A/S